Filing Flows

Filing Flows › 8-K events › Rockwell Medical

Rockwell Medical: entry into a material definitive agreement

Form 8-K filed Nov 3, 2026 · items 1.01, 3.02, 7.01

Entry into a material definitive agreementRockwell Medical Announces Transformational Global Hemodialysis Acquisition

What the filing says

On November 2, 2026, Rockwell Medical, Inc. (the “Company”) entered into an Equity and Asset Purchase Agreement (the “Purchase Agreement”) with Vantive Limited, a company incorporated under the laws of Jersey (“Vantive”). Pursuant to the Purchase Agreement, the Company agreed to acquire Vantive’s in-center hemodialysis

Read the filing on SEC EDGAR →

What usually followsAcross 23,525 8-Ks reporting Item 1.01 (material definitive agreement) in our universe, the stock's median move the next session was 0.0% (typical size ±1.4%, up 51% of the time); over the following 21 sessions, +1.0%. Item 3.02: +0.1% next session across 2,750. Every item ranked →

What this kind of filing means

Item 1.01 — Entry into a material definitive agreement. A material agreement is one the company considers important enough to disclose within four business days: a merger agreement, a large supply or customer contract, a credit agreement or a licence. The terms often move the company’s outlook more than a quarter’s results.

Rockwell Medical at a glance

Latest quarterQ2 2026
Revenue$17.8M
Revenue Y/Y+11%
Operating margin-6.0%
IndustryPharmaceutical Preparations

Rockwell Medical, Q2 2026: revenue $17.8M (+11% year over year), operating margin -6.0%. The chart follows the revenue to costs, profit and cash.

Rockwell Medical: every quarter, Q/Q and Y/Y, holders and guidance →

Other recent guidance

Read automatically from SEC EDGAR (13F, Form 4, Form 144, Schedule 13D/G, 8-K, XBRL), House and Senate disclosures, FINRA and exchange data; errors are possible. Not investment advice.